Agios Pharmaceuticals Inc. (NASDAQ: AGIO) announced that new data on mitapivat, an oral pyruvate kinase activator, will be presented at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE